SCHEMBL27350102

SCHEMBL27350102

C=Cc1cnc(C)cc1C(=C)Cl

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ UHRF1 Q96T88 1/20 0.31
▸ PDXK O00764 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27340729 0.74 UHRF1 (0.38) UHRF1
SCHEMBL15250375 0.73 ALDH1A1 (0.35) UHRF1
SCHEMBL23449165 0.73 UHRF1 (0.31) UHRF1
SCHEMBL18885307 0.72 UHRF1 (0.46) UHRF1
SCHEMBL28256541 0.69 UHRF1 (0.48) UHRF1
SCHEMBL11013572 0.69 PDXK (0.45) UHRF1PDXK
SCHEMBL17053139 0.69 UHRF1 (0.41) UHRF1
SCHEMBL31149578 0.68 TSHR (0.39) —
SCHEMBL23449164 0.68 TSHR (0.39) —
SCHEMBL31149537 0.68 GABRP (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250165-A1 SALTS OF SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-28 — — WO disclosed
Send feedback